American Cancer Society's Complete Guide to Prostate Cancer by David G. Bostwick (Editor), E. David Crawford (Editor), Celestia S. Higano (Editor)

Product Details

Synopsis

"This comprehensive guide provides the latest information about symptoms, diagnosis, and treatment options as well as practical advice about coping with the healthcare system, insurance providers, and the emotional aspects of the disease. . . . An excellent title."

—Library Journal, May 1, 2005

Written by the top experts in the field, this essential guide provides you with up-to-date, evidence-based information about every aspect of prostate cancer, from who is at risk, to diagnostic tests and treatment, to living well after treatment. American Cancer Society’s Complete Guide to Prostate Cancer explores:

• The latest advances in prevention, early detection, and treatment
• The range of treatment options available and their advantages, expected outcomes, and potential side effects
• How to cope with emotional stresses and potential physical side effects such as incontinence and erectile dysfunction
• How to maintain quality of life, sexuality, and relationships
• Practical issues like managing medical records, work, and insurance

Highlighted by personal stories from people affected by prostate cancer, American Cancer Society’s Complete Guide to Prostate Cancer also addresses follow-up care, the risk of recurrence, and scientific advances and promising research. A special section helps loved ones understand, cope, and provide support.

Library Journal

Prostate cancer (PCa) is the most common type of cancer among men, killing some 42,000 every year. Two new guides seek to provide the latest information on the disease and the treatments available. Written by leading medical experts, the American Cancer Society's Complete Guide is an accessible and comprehensive survey that describes PCa and explains who is at risk, backing up its discussions with statistics. Symptoms, early detection, and what to expect when seeing a doctor are also addressed. Confusing diagnostic medical terminology and acronyms are explained in the text and conveniently repeated in the glossary. The volume also outlines treatment options-e.g., watchful waiting, hormonal therapy, radiation and brachytherapy, surgery, and cryotherapy-and details the combination of factors that predict outcomes. There is advice on how to manage the medical establishment, deal with insurance, assure emotional support for the patient and his family, and contact support groups. Bubley (genitourinary oncology, Beth Israel Deaconess Medical Ctr., Boston) explains how, owing to increased public awareness and improved screening tests, PCa is more often detected at its earliest and most treatable stages. With over 25 years' experience in conventional and experimental prostate cancer therapies, Bubley clearly discusses the natural remedies and alternative medicines that can complicate treatment and may have adverse consequences if the doctor is not kept informed of their use. Bubley hopes his overview will open and encourage patient/physician dialog about treatment options and possible changes in diet and lifestyle to help maintain wellness and improve prostate health. Both guides are good choices for consumer health collections, but if funds are limited, stick to the excellent American Cancer Society title.-James Swanton, Harlem Hosp. Lib., New York Copyright 2004 Reed Business Information.

Biography

David G. Bostwick, M.D., MBA, is a clinical professor of pathology at the University of Virginia in Charlottesville and medical director of Bostwick Laboratories in Richmond.

E. David Crawford, M.D., is the associate director of the University of Colorado Comprehensive

Cancer Center in Aurora. He is also professor of surgery and radiation oncology and head of urologic oncology at the University of Colorado Health Sciences Center in Aurora.

Celestia S. Higano, M.D., is an oncology specialist at the Seattle Cancer Care Alliance and is an associate professor of the department of medicine and the department of urology at the University of Washington School of Medicine in Seattle.

Mack Roach III, M.D., is a professor of radiation oncology and urology and director of clinical

research in radiation oncology at the University of California at San Francisco.